A detailed history of Operose Advisors LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Operose Advisors LLC holds 375 shares of BDX stock, worth $83,212. This represents 0.03% of its overall portfolio holdings.

Number of Shares
375
Previous 375 -0.0%
Holding current value
$83,212
Previous $87,000 3.45%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$232.24 - $267.23 $42,267 - $48,635
-182 Reduced 32.68%
375 $91,000
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $90,999 - $101,241
357 Added 178.5%
557 $144,000
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $46,016 - $50,188
200 New
200 $50,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.